Lee, H. J., Henke, L. E., Dorth, J. A., Lumish, M. A., Conces, M., Mohamed, A., Chakrabarti, S., Mahipal, A., Selfridge, J. E., Ammori, J. B., Hardacre, J., Winter, J. M., Bajor, D. L. (2025). A phase I, single-center, open label, dose de-escalation and expansion study of Ivosidenib + mFOLFIRINOX in patients with resectable pancreatic adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps794